Zoxazolamine-induced paralysis in two rat substrains: Differences in hepatic drug metabolism

European Journal of Drug Metabolism and Pharmacokinetics

Volumn 23, Issue 4, 1998, Pages 461-467

  Pappas, P ^a   Stephanou, P ^a   Vasiliou, V ^b   Marselos, M ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Aldehyde dehydrogenase; Induction; Phenobarbital; Wistar rat; Zoxazolamine

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; 3 METHYLCHOLANTHRENE; ALDEHYDE DEHYDROGENASE; ETHOXYRESORUFIN DEETHYLASE; MUSCLE RELAXANT AGENT; PENTOXYRESORUFIN DEALKYLASE; PHENOBARBITAL; POLYCYCLIC AROMATIC HYDROCARBON; ZOXAZOLAMINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; DEALKYLATION; DRUG METABOLISM; ENZYME ACTIVITY; ENZYME INDUCTION; EXPERIMENTAL MODEL; LIVER METABOLISM; MALE; NONHUMAN; PARALYSIS; RAT;

EID: 0032419411     PISSN: 03787966     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03189996     Document Type: Conference Paper

References (18)

1. Esterbauer H. (1982): Aldehydic products of lipid peroxidation. In: McBrien D.C.H. and Slater T.F. (Eds.). Free Radicals, Lipid Peroxidation and Cancer. 101-128. Academic Press, N.Y.
2. Esterbauer H., Zollner H., Schaur R.J. (1990): Aldehydes formed by lipid peroxidation: mechanisms of formation, occurrence and determination. In: Vigo Pelfrey C. (Ed.). Membrane Lipid Oxidation. Florida, CRC Press, vol 1.
3. Marselos M., Lindahl R. (1988): Substrate preference of a cytosolic aldehyde dehydrogenase inducible in rat liver by treatment with 3-methylcholanthrene. Toxicol Appl. Pharmacol., 95, 339-345.
4. Lindahl R. (1992): Aldehyde dehydrogenases and their role in carcinogenesis. Cr. Rev. Biochem. Mol. Biol., 27, 283-335.
5. Mitchel D.Y., Petersen D.R. (1987): The oxidation of ÿ,Ö-unsaturated aldehydic products of lipid peroxidation by rat liver aldehyde dehydrogenases. Toxicol. Appl. Pharmacol., 87, 403-410.
6. Esterbauer H. (1993): Cytotoxicity and genotoxicity of lipid-oxidation products. Am. J. Clin. Nutr., 57(5S), 779S-785S.
7. Deitrich R.A. (1966): Tissue and sub-cellular distribution of mammalian aldehyde- oxidizing capacity. Biochem. Pharmacol., 15, 1911-1922.
8. Vasiliou V., Marselos M. (1989): Tissue distribution of inducible aldehyde dehydrogenase activity in the rat after treatment with phenobarbital and methylcholanthrene. Pharmacol. Toxicol., 64, 39-42.
9. Pappas P., Stephanou P., Vasiliou V., Karamanakos P., Marselos M. (1997): Ontogenesis and expression of ALDH activity in the skin and the eye of the rat. Adv. Exp. Med. Biol., 414, 73-80.
10. Deitrich R.A. (1971): Genetic aspects of increase in rat liver aldehyde dehydrogenase induced by phenobarbital. Science, 173, 334-336.
11. Marselos M. (1976): Genetic variation of drug-metabolizing enzymes in the Wistar rat. Acta Pharmacol. Toxicol., 39, 186-197.
12. Marselos M., Vasiliou V. (1991): Effect of various chemicals on the aldehyde dehydrogenase activity of the rat liver cytosol. Chem-Biol. Interact., 79, 79-89.
13. Marselos M., Michalopoulos G. (1986): Phenobarbital enhances the aldehyde dehydrogenase activity of rat hepatocytes in vitro and in vivo. Acta Pharmacol. Toxicol., 59, 403-409.
14. Burke M.B., Mayer R.T. (1975): Inherent specificities of purified cytochromes P-450 and P-448 toward biphenyl hydroxylation and ethoxyresorufin deethylation. Drug Metabol. Dispos., 3, 245-253.
15. Lowry O.H., Rosebrough N.J., Fair A.L., Randall R.J. (1951): Protein measurement with Folin phenol reagent. J. Biol. Chem., 193, 265-275.
16. Liang H.C., Li H., McKinnon R.A., Duffy J.J., Potter S.S., Puga A., Nebert D.W. (1996): Cypla2(-/-) null mutant mice develop normally but show deficient drug metabolism. Proc. Natl. Acad. Sci. USA., 93(4), 1671-1676.
17. Robinson J.R. and Nebert D.W. (1973): Genetic expression of aryl hydrocarbon hydroxylase induction. Mol. Pharmacol., 10, 484-493.
18. Van der Graaff M., Vermeulen N.P.E., Breimer D.D. (1988): Disposition of hexobarbital: 15 years of an intriguing model substrate. Drug Metabol. Rev., 19(2), 1-109.